152 related articles for article (PubMed ID: 6965234)
1. Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.
Fossati G; Balsari A; Taramelli D; Sensi ML; Pellegris G; Nava M; Parmiani G
Cancer Immunol Immunother; 1982; 14(2):99-104. PubMed ID: 6965234
[TBL] [Abstract][Full Text] [Related]
2. Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
Strausser JL; Mazumder A; Grimm EA; Lotze MT; Rosenberg SA
J Immunol; 1981 Jul; 127(1):266-71. PubMed ID: 7195411
[TBL] [Abstract][Full Text] [Related]
3. Control of human melanoma growth in nude mice by autologous allo-activated peripheral blood lymphocytes.
Balsari A; Tona G; Colombo MP; Fossati G; Parmiani G
Int J Cancer; 1986 Dec; 38(6):923-7. PubMed ID: 3793266
[TBL] [Abstract][Full Text] [Related]
4. Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.
Slingluff CL; Darrow TL; Seigler HF
Ann Surg; 1989 Aug; 210(2):194-202. PubMed ID: 2787972
[TBL] [Abstract][Full Text] [Related]
5. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
Mazumder A; Grimm EA; Zhang HZ; Rosenberg SA
Cancer Res; 1982 Mar; 42(3):913-8. PubMed ID: 7059990
[TBL] [Abstract][Full Text] [Related]
6. Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma.
Balsari A; Fossati G; Taramelli D; Tona G; Delia D; Giardini R; Parmiani G
Br J Cancer; 1985 Jul; 52(1):73-80. PubMed ID: 3160380
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
[TBL] [Abstract][Full Text] [Related]
8. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
9. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
Radrizzani M; Gambacorti-Passerini C; Parmiani G; Fossati G
Cancer Immunol Immunother; 1989; 28(1):67-73. PubMed ID: 2462469
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
11. Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.
Taramelli D; Mazzocchi A; Clemente C; Fossati G; Parmiani G
Cancer Immunol Immunother; 1988; 26(1):61-6. PubMed ID: 3345538
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.
Mizutani Y; Yoshida O; Miki T
J Urol; 1999 Dec; 162(6):2170-5. PubMed ID: 10569614
[TBL] [Abstract][Full Text] [Related]
13. Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.
Mazumder A; Grimm EA; Rosenberg SA
Cancer Immunol Immunother; 1983; 15(1):1-10. PubMed ID: 6603260
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
Mukherji B; Wilhelm SA; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
16. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human melanoma growth in nude mice by autologous, alloactivated peripheral blood lymphocytes.
Balsari A; Fossati G; Taramelli D; Nava M; Ravagnani F; Parmiani G
Tumori; 1984 Feb; 70(1):35-9. PubMed ID: 6710607
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
19. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
